STOCK TITAN

Accelevation closes IPO with 10M company shares at $18

Seven directors were appointed, and Accelevation adopted amended governing documents and a 2026 incentive plan.

(High)

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

Form Type
8-K

Rhea-AI Filing Summary

Accelevation Holdings Corp. (ACCV) closed its IPO on October 1, 2026, and delivered the Firm Shares: the company sold 10,000,000 shares of Class A common stock and the selling stockholders sold 20,000,000 shares, at $18.00 per share. The selling stockholders also granted the underwriters a 30-day option to purchase up to 4,500,000 additional Class A shares.

In connection with the IPO, Accelevation issued 116,965,529 shares of Class B common stock to Accelevation Investment Holdings LLC in an unregistered issuance relying on Section 4(a)(2) and Rule 506. Seven directors—Manu Bettegowda, Matt Bujor, Robert Morris, Paul Donahue, Howard Heckes, Ginger Jones, and Martin Durkin—were appointed on September 29, 2026. The company also adopted amended and restated governing documents effective that day, entered registration rights, director nomination, tax receivable, exchange and LLC agreements, adopted its 2026 Omnibus Incentive Plan, and entered indemnification agreements with its directors and executive officers.

Insights

Analyzing...

Item 1.01 Entry into a Material Definitive Agreement Business
The company signed a significant contract such as a merger agreement, credit facility, or major partnership.
Item 3.02 Unregistered Sales of Equity Securities Securities
The company sold equity securities in a private placement or other unregistered transaction.
Item 3.03 Material Modification to Rights of Security Holders Securities
A change was made that materially affects the rights of existing shareholders (e.g., dividend rights, voting rights).
Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers Governance
Key personnel changes including departures, elections, or appointments of directors and executive officers.
Item 5.03 Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year Governance
The company amended its charter documents, bylaws, or changed its fiscal year.
Item 9.01 Financial Statements and Exhibits Exhibits
Financial statements, pro forma financial information, or exhibit attachments filed with this report.
Class A shares sold by the company 10,000,000 shares IPO; closed October 1, 2026
Class A shares sold by selling stockholders 20,000,000 shares IPO; closed October 1, 2026
Public offering price $18.00 per share IPO Firm Shares
Additional-share option Up to 4,500,000 shares Granted by selling stockholders to underwriters for 30 days
Class B common stock issued 116,965,529 shares Issued to Accelevation Investment Holdings LLC in connection with the IPO
Directors appointed 7 directors September 29, 2026
Firm Shares financial
"collectively, the “Firm Shares”"
Tax Receivable Agreement financial
"the Tax Receivable Agreement, dated as of September 30, 2026"
A contract in which a company agrees to pay a specified party (often former owners after a spinoff or IPO) a share of future tax savings the company realizes. Think of it like agreeing to share a future tax refund with someone who helped create the conditions for that refund. For investors it matters because those payments reduce the cash the company can use for dividends, buybacks, or reinvestment, and therefore affect valuation and returns.
Rule 506 regulatory
"Section 4(a)(2) of the Securities Act and Rule 506"
A Securities and Exchange Commission rule that lets companies sell securities without registering them with the SEC when they meet certain conditions, commonly used for private placements. It allows issuers to raise unlimited capital from accredited investors and, in some versions, a small number of knowledgeable non‑accredited investors; one version also permits public advertising if the seller takes steps to verify investor credentials. For investors, it signals a private offering with lighter disclosure and different protections than a public stock sale, similar to buying into a private club rather than a publicly traded marketplace.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How many ACCV shares were sold in the IPO, and at what price?

The company sold 10,000,000 Class A common shares and selling stockholders sold 20,000,000, at $18.00 per share. The IPO closed on October 1, 2026, and the Firm Shares were delivered.

How many Class B shares did ACCV issue in connection with its IPO?

Accelevation issued 116,965,529 shares of Class B common stock to Accelevation Investment Holdings LLC. The unregistered issuance relied on Section 4(a)(2) and Rule 506.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Learn about SEC filing dates
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): September 29, 2026
Accelevation Holdings Corp.
(Exact name of registrant as specified in its charter)
Delaware
001-43490
42-3222150
(State or other jurisdiction
of incorporation)
(Commission
File Number)
(IRS Employer
Identification No.)
9555 N. Springboro Pike, Suite 400
Miamisburg, Ohio
45342
(Address of principal executive offices)
(Zip Code)
Registrant’s telephone number, including area code: (937) 258-0616
Not Applicable
(Former name or former address, if changed since last report.)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the
following provisions:
☐
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
☐
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
☐
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
☐
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Securities registered pursuant to Section 12(b) of the Act:
Title of each class
Trading
Symbol(s)
Name of each exchange
on which registered
Class A common stock, par value $0.0001 per share
ACCV
The Nasdaq Stock Market LLC
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this
chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging growth company
☒
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any
new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.    ☐
Item 1.01.Entry into a Material Definitive Agreement.
On September 29, 2026, Accelevation Holdings Corp. (the “Company”), Accelevation LLC (“Accelevation
LLC”) and Accelevation Cash Pubco Holdings LP (“Accelevation Cash Pubco Holdings”) and Accelevation
Investment Holdings LLC (“Investment Holdings” together, with Accelevation Cash Pubco Holdings, the “Selling
Stockholders”), entered into an underwriting agreement (the “Underwriting Agreement”) with Morgan Stanley &
Co. LLC and J.P. Morgan Securities LLC, as representatives of the several underwriters named in Schedule II
thereto (collectively, the “Underwriters”) relating to the initial public offering (the “IPO”) of the Company’s Class A
common stock, par value $0.0001 per share (“Class A Common Stock”). The Underwriting Agreement provides for
the offer and sale by the Company of 10,000,000 shares of Class A Common Stock and by the Selling Stockholders
of 20,000,000 shares of Class A Common Stock (collectively, the “Firm Shares”) at a public offering price of $18.00
per share. Pursuant to the Underwriting Agreement, the Selling Stockholders granted the Underwriters a 30-day
option to purchase up to an additional 4,500,000 shares of Class A Common Stock. On October 1, 2026, the IPO
closed and the Firm Shares were delivered. The material terms of the Underwriting Agreement are described in the
prospectus, dated September 29, 2026 (the “Prospectus”), filed by the Company with the U.S. Securities and
Exchange Commission (the “Commission”) on October 1, 2026, pursuant to Rule 424(b) under the Securities Act of
1933, as amended (the “Securities Act”). The IPO is registered with the Commission pursuant to the Company’s
Registration Statement on Form S-1, as amended (File No. 333-298715).
The Underwriting Agreement contains customary representations and warranties, agreements and
obligations, closing conditions and termination provisions. The Company and the Selling Stockholders have agreed
to indemnify the Underwriters against (or contribute to the payment of) certain liabilities, including liabilities under
the Securities Act. This description of the Underwriting Agreement is qualified in its entirety by reference to the full
text of the Underwriting Agreement attached hereto as Exhibit 1.1, which is incorporated by reference into this Item
1.01. Additionally, for a summary description of relationships between the Company and the Underwriters, see the
section entitled “Underwriting” in the Prospectus.
In connection with the consummation of the IPO, the Company entered into the following additional
agreements:
•the Registration Rights Agreement, dated as of September 29, 2026, by and among the Company,
Accelevation Pubco Holdings LP (“Pubco Holdings”) and Investment Holdings, a copy of which is filed
as Exhibit 4.1 to this Current Report on Form 8-K and is incorporated by reference herein;
•the Director Nomination Agreement, dated as of September 29, 2026, by and among the Company,
Pubco Holdings, Investment Holdings, Michael Rubiera and the other parties signatory thereto, a copy
of which is filed as Exhibit 10.1 to this Current Report on Form 8-K and is incorporated by reference
herein;
•the Limited Liability Company Agreement of Accelevation Holdings LLC (“Holdings LLC”), dated as
of September 30, 2026, by and among the Company and the other signatories party thereto, a copy of
which is filed as Exhibit 10.2 to this Current Report on Form 8-K and is incorporated by reference
herein;
•the Tax Receivable Agreement, dated as of September 30, 2026, by and among the Company, Holdings
LLC, Instor Blocker, Inc. (“Instor”) and Investment Holdings, a copy of which is filed as Exhibit 10.3 to
this Current Report on Form 8-K and is incorporated by reference herein; and
•the Exchange Agreement, dated as of September 30, 2026, by and among the Company, Holdings LLC,
Instor and Investment Holdings, a copy of which is filed as Exhibit 10.4 to this Current Report on Form
8-K and is incorporated by reference herein.
Descriptions of these agreements are contained in the Prospectus in the sections entitled “Certain
Relationships and Related Party Transactions” and “Organizational Structure” and are incorporated by reference into
this Item 1.01. Such descriptions are qualified in their entirety by reference to the full text of each of the agreements
attached hereto as Exhibits 4.1, 10.1, 10.2, 10.3 and 10.4, which are incorporated by reference into this Item 1.01.
Item 3.02.Unregistered Sales of Equity Securities.
In connection with the consummation of the IPO and as contemplated by the transactions described in the
Prospectus under “Organizational Structure,” which section is incorporated by reference into this Item 3.02, the
Company issued to Investment Holdings 116,965,529 shares of Class B common stock, par value $0.0001 per share
(the “Class B Common Stock”). A description of the designations, rights, powers and preferences of the Class B
Common Stock is contained in the Prospectus in the section entitled “Description of Capital Stock” and is
incorporated by reference into this Item 3.02. The issuance of the Class B Common Stock described in this
paragraph was made in reliance on Section 4(a)(2) of the Securities Act and Rule 506 promulgated thereunder.
Item 3.03.Material Modification to Rights of Security Holders.
The information provided under Item 5.03 of this Current Report on Form 8-K is incorporated by reference
into this Item 3.03.
Item 5.02.Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain
Officers; Compensatory Arrangements of Certain Officers.
On September 29, 2026, Manu Bettegowda, Matt Bujor, Robert Morris, Paul Donahue, Howard Heckes,
Ginger Jones, and Martin Durkin were appointed to the Company’s board of directors. Biographical information and
other information regarding the committees upon which Messrs. Bettegowda, Bujor, Morris, Donahue, Heckes, and
Durkin, and Ms. Jones are expected to serve, related party transactions involving any of these directors, the
compensation plans in which these directors participate and information about any arrangement or understanding
between these directors and any other persons pursuant to which these directors were selected as a director are
included in the Prospectus in the sections entitled “Certain Relationships and Related Party Transactions,”
“Executive Compensation,” and “Management” and are incorporated by reference into this Item 5.02.
On or around September 29, 2026, in connection with the IPO, the Company entered into indemnification
agreements with each of its directors and executive officers. These agreements provide the Company’s directors and
executive officers with contractual rights to indemnification, expense advancement and reimbursement, to the fullest
extent permitted under the Delaware General Corporation Law. These indemnification rights are not exclusive of
any other right that an indemnified person may have or hereafter acquire under any statute, provision of the
Company’s Certificate of Incorporation or Bylaws (each as defined below), any agreement, or vote of stockholders
or disinterested directors or otherwise. This description of the indemnification agreements is qualified in its entirety
by reference to the form of director and officer indemnification agreement attached hereto as Exhibit 10.5, which is
incorporated by reference into this Item 5.02.
Additionally, on September 29, 2026, and in connection with the IPO, the Company adopted the
Accelevation Holdings Corp. 2026 Omnibus Incentive Plan (the “Omnibus Plan”). A description of the Omnibus
Plan is contained in the Prospectus in the section entitled “Executive Compensation—Actions Taken in Connection
with this Offering—Omnibus Incentive Plan” and is incorporated by reference into this Item 5.02. Such description
is qualified in its entirety by reference to the full text of the Omnibus Plan attached hereto as Exhibit 10.6, which is
incorporated by reference into this Item 5.02.
Item 5.03.Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year.
On September 29, 2026, the Company filed an amended and restated certificate of incorporation (the
“Certificate of Incorporation”) with the Secretary of State of the State of Delaware and adopted amended and
restated bylaws (the “Bylaws”), each of which became effective on September 29, 2026. A description of the
Certificate of Incorporation and the Bylaws is contained in the Prospectus in the section entitled “Description of
Capital Stock” and is incorporated by reference into this Item 5.03. Such description is qualified in its entirety by
reference to the full text of the Certificate of Incorporation attached hereto as Exhibit 3.1 and the full text of the
Bylaws attached hereto as Exhibit 3.2, both of which are incorporated by reference into this Item 5.03.
Item 9.01.Financial Statements and Exhibits.
(d) Exhibits.
Exhibit No.
Description
1.1
Underwriting Agreement, dated as of September 29, 2026, by and among Accelevation Holdings Corp., Accelevation LLC,
the selling stockholders named in Schedule I thereto and Morgan Stanley & Co. LLC and J.P. Morgan Securities LLC, as
representatives of the several underwriters named in Schedule II thereto.
3.1
Amended and Restated Certificate of Incorporation of Accelevation Holdings Corp.
3.2
Amended and Restated Bylaws of Accelevation Holdings Corp.
4.1
Registration Rights Agreement, dated September 29, 2026, by and among Accelevation Holdings Corp., Accelevation Pubco
Holdings LP and Accelevation Investment Holdings LLC.
10.1
Director Nomination Agreement, dated as of September 29, 2026, by and among Accelevation Holdings Corp., Accelevation
Pubco Holdings LP, Accelevation Investment Holdings LLC, Michael Rubiera and the other parties signatory thereto.
10.2
Limited Liability Company Agreement of Accelevation Holdings LLC, dated as of September 30, 2026, by and among
Accelevation Holdings Corp. and the other parties signatory thereto.
10.3
Tax Receivable Agreement, dated as of September 30, 2026, by and among Accelevation Holdings Corp., Accelevation
Holdings LLC, Instor Blocker, Inc. and Accelevation Investment Holdings LLC.
10.4
Exchange Agreement, dated as of September 30, 2026, by and among Accelevation Holdings Corp., Accelevation Holdings
LLC, Instor Blocker, Inc. and Accelevation Investment Holdings LLC.
10.5
Form of Indemnification Agreement between Accelevation Holdings Corp. and each of its directors and executive officers
(incorporated by reference to Exhibit 10.12 to the Company’s Registration Statement on Form S-1 filed with the Commission
on September 11, 2026).
10.6
Accelevation Holdings Corp. 2026 Omnibus Incentive Plan.
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this
report to be signed on its behalf by the undersigned hereunto duly authorized.
ACCELEVATION HOLDINGS CORP.
Date: October 1, 2026
By:
/s/ Michael Rubiera
Name:
Michael Rubiera
Title:
Chief Executive Officer

Filing Exhibits & Attachments

10 documents

Keep reading